DOK7 and breast cancer: A recent study showed that DNA hypermethylation of DOK7 had been detected in breast cancer samples (blood from breast cancer patients, breast cancer tumors, and breast cancer cell lines), suggesting that DOK7 promoter methylation could become a novel molecular biomarker in early detection of breast cancer [18, 25].